Recorlev Lessens Cushing’s Symptoms, Eases Depression, SONICS Trial Data Show
News
Recorlev (levoketoconazole), Strongbridge Biopharma’s oral investigational therapy, lessens disease symptoms and depression, and improves quality of life among people with endogenous Cushing’s syndrome, according to data from the Phase ... Read more